Jerry C. Griffin - 11 Nov 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Jerry C. Griffin
Issuer symbol
INSP
Transactions as of
11 Nov 2022
Net transactions value
-$2,030,253
Form type
4
Filing time
14 Nov 2022, 20:13:14 UTC
Previous filing
10 May 2022
Next filing
01 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $7,067 +7,518 $0.9400 7,518 11 Nov 2022 Direct
transaction INSP Common Stock Options Exercise $3,533 +3,759 +50% $0.9400 11,277 11 Nov 2022 Direct
transaction INSP Common Stock Sale $1,315,409 -5,951 -53% $221.04 5,326 11 Nov 2022 Direct
transaction INSP Common Stock Sale $725,444 -3,266 -61% $222.12 2,060 11 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -7,518 -100% $0.000000* 0 11 Nov 2022 Common Stock 7,518 $0.9400 Direct F2
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -3,759 -100% $0.000000* 0 11 Nov 2022 Common Stock 3,759 $0.9400 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.05 to $222.38. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option is fully vested and exercisable.